EICHOR
● Recruiting
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
Condition: C3 Glomerulopathy (C3G) · Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) · Sponsor: Swedish Orphan Biovitrum
About this study
The purpose of this study is to evaluate the effectiveness and safety of Pegcetacoplan in patients with C3G and primary IC-MPGN in the real-world setting. This study will also assess biomarkers not routinely measured in clinical practice. Results will support the long-term evaluation of the benefit-risk profile of pegcetacoplan in a broad patient population, informing clinical decision-making.
This description comes directly from the study's public registry record.
Talk to the study team
Study Physician · +46 86972000 · medical.info@sobi.com
Always discuss trial participation with your own doctor first.
Locations (101)
| Nepean Hospital | Kingswood, Australia | Not Yet Recruiting |
| Princess Alexandra Hospital | Woolloongabba, Australia | Not Yet Recruiting |
| Medizinische Universität Graz | Graz, Austria | Not Yet Recruiting |
| Uniklinik Innsbruck | Innsbruck, Austria | Not Yet Recruiting |
| Allgemeines Krankenhaus Wien Universitätsklinik | Vienna, Austria | Not Yet Recruiting |
| Klinik Ottakring | Vienna, Austria | Not Yet Recruiting |
| Cliniques Universitaires Saint-Luc | Brussels, Belgium | Not Yet Recruiting |
| University hosptial of Antwerpen | Edegem, Belgium | Not Yet Recruiting |
| Grand Hôpital de Charleroi | Gilly, Belgium | Not Yet Recruiting |
| UZ Leuven | Leuven, Belgium | Not Yet Recruiting |
| Centre Hospitalier Universitaire de Liege | Liège, Belgium | Not Yet Recruiting |
| CHU UCL Namur | Namur, Belgium | Not Yet Recruiting |
+ 89 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07746895